Novacyt S.A.

ALNOV.PA · PAR
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Market Cap€35,189€43,635€76,773€260,198
- Cash€30,453€44,054€86,973€101,746
+ Debt€11,878€13,704€872€1,870
Enterprise Value€16,614€13,285-€9,328€160,322
Revenue€19,630€11,579€21,040€95,780
% Growth69.5%-45%-78%
Gross Profit€32,074€3,730€5,746€29,678
% Margin163.4%32.2%27.3%31%
EBITDA-€34,309-€18,243-€11,677-€4,197
% Margin-174.8%-157.6%-55.5%-4.4%
Net Income-€41,758-€28,292-€22,201-€9,728
% Margin-212.7%-244.3%-105.5%-10.2%
EPS Diluted-0.59-0.4-0.31-0.14
% Growth-47.5%-29%-121.4%
Operating Cash Flow-€9,149-€24,991-€13,729€15,689
Capital Expenditures-€1,861-€671-€416-€4,100
Free Cash Flow-€11,010-€25,662-€14,145€11,589
Novacyt S.A. (ALNOV.PA) Financial Statements & Key Stats | AlphaPilot